Richard Hernandez
- Co-authors
- Semiramis Ayral‐KaloustianCarl F. BeyerThai NguyenJudy LucasJames J. GibbonsNan ZhangCarolyn DiscafaniArie Zask
- Topics
- Immunotherapy and Immune Responses (5 papers)Cancer Immunotherapy and Biomarkers (5 papers)Chronic Lymphocytic Leukemia Research (3 papers)
- Journals
- Journal of Clinical OncologySHILAP Revista de lepidopterologíaCancer Research
- Partner nations
- United StatesCanada
In The Last Decade
Richard Hernandez
13 papers receiving 517 citations
Peers
Comparison fields: 5 of 65
- Organic Chemistry 270
- Molecular Biology 220
- Oncology 121
- Cell Biology 73
- Pharmacology 58
Countries citing papers authored by Richard Hernandez
This map shows the geographic impact of Richard Hernandez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Hernandez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Hernandez more than expected).
Fields of papers citing papers by Richard Hernandez
This network shows the impact of papers produced by Richard Hernandez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Hernandez. The network helps show where Richard Hernandez may publish in the future.
Co-authorship network of co-authors of Richard Hernandez
This figure shows the co-authorship network connecting the top 25 collaborators of Richard Hernandez. A scholar is included among the top collaborators of Richard Hernandez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard Hernandez. Richard Hernandez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 1 | |
| 3 | 14 | |
| 4 | 8 | |
| 5 | 2 | |
| 6 | 39 | |
| 7 | 20 | |
| 8 | 72 | |
| 9 | 25 | |
| 10 | 54 | |
| 11 | 180 | |
| 12 | 16 | |
| 13 | HTI-286, a synthetic analogue of the tripeptide hemiasterlin, is a potent antimicrotubule agent that circumvents P-glycoprotein-mediated resistance in vitro and in vivo. | 97 |
About Richard Hernandez
Richard Hernandez is a scholar working on Oncology, Genetics and Immunology, having authored 13 papers that have together received 530 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (5 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Chronic Lymphocytic Leukemia Research (3 papers). The work is most often cited by research in Organic Chemistry (270 citations), Pharmaceutical Science (31 citations) and Cell Biology (73 citations). Richard Hernandez has collaborated with scholars based in United States and Canada. Frequent co-authors include Semiramis Ayral‐Kaloustian, Carl F. Beyer, Thai Nguyen, Judy Lucas, James J. Gibbons, Nan Zhang, Carolyn Discafani, Nan Zhang, Arie Zask and Sylvia Musto. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.